Showing results (21-30 of 39) with videos related to
Sort By:
Pageof 4
The Journal of Antimicrobial Chemotherapy|May 17, 2012
High frequency of vitamin D deficiency in HIV-infected patients: effects of HIV-related factors and antiretroviral drugsC Allavena, C Delpierre, L Cuzin, et al.Medecine Et Maladies Infectieuses|December 3, 2009
[Impact of malaria on HIV infection]G Martin-Blondel, M Soumah, B Camara, et al.Plos One|September 7, 2019
Too fast to stay on track? Shorter time to first anti-retroviral regimen is not associated with better retention in care in the French Dat'AIDS cohortL Cuzin, L Cotte, C Delpierre, et al.HIV Medicine|May 10, 2013
An undetectable polymerase chain reaction signal in routine HIV plasma viral load monitoring is associated with better virological outcomes in patients receiving highly active antiretroviral therapyP Pugliese, C Delpierre, L Cuzin, et al.Alimentary Pharmacology & Therapeutics|June 15, 2018
Risk of diabetes in HIV-infected patients is associated with cirrhosis but not with chronic HCV coinfection in a French nationwide HIV cohortA Provoost, M Dramé, L Cotte, et al.Leukemia|January 23, 2009
The level of AKT phosphorylation on threonine 308 but not on serine 473 is associated with high-risk cytogenetics and predicts poor overall survival in acute myeloid leukaemiaN Gallay, C Dos Santos, L Cuzin, et al.HIV Medicine|August 24, 2017
No relationship between late HIV diagnosis and social deprivation in newly diagnosed patients in FranceL Cuzin, Y Yazdanpanah, T Huleux, et al.The Journal of Nutrition, Health & Aging|March 22, 2016
Impact of Age-related Comorbidities on Five-year Overall Mortality among Elderly HIV-Infected Patients in the Late HAART Era--Role of Chronic Renal DiseaseM Hentzien, M Dramé, C Allavena, et al.Presse Medicale (Paris, France : 1983)|March 1, 2003
[NADIS 2000, development of an electronic medical record for patients infected by HIV, HBV and HCV]P Pugliese, L Cuzin, P Enel, et al.Medecine Et Maladies Infectieuses|November 10, 2018
Which antiretrovirals should be prescribed as first-line treatments? Changes over the past 10 years in FranceP Pugliese, V Joly, M A Valantin, et al.Pageof 4